9
Views
7
CrossRef citations to date
0
Altmetric
Original Article

Identification of a Cyanogen Bromide Fragment of Porcine Type II Collagen Capable of Modulating Collagen Arthritis in B10.RIII (H-2r) Mice

, , , &
Pages 39-49 | Received 03 Jan 1994, Published online: 07 Jul 2009

References

  • Trentham D. E., Townes A. S., Kang A. H. Autoimmunity to type II collagen: an experimental model of arthritis. J. Exp. Med. 1977; 146: 857
  • Trentham D. E., Townes A. S., Kang A. H. Humoral and cellular sensitivity to collagen in type II collagen-induced arthritis in rats. J. Clin. Invest. 1978; 61: 89
  • Trentham D. E., Dynesius R. A., David J. R. Passive transfer by cells of type II collagen-induced arthritis in rats. J. Clin. Invest. 1978; 62: 359
  • Wooley P. H., Luthra H. S., Stuart J. M., David C. S. Type II collagen-induced arthritis in mice. I. Major histocompatibility complex (I region) linkage and antibody correlates. J. Exp. Med. 1981; 154: 688
  • Wooley P. H., Luthra H. S., Griffiths M. M., Stuart J. M., Huse A., David C. S. Type II collagen-induced arthritis in mice. IV. Variations in immunogenetic regulation provide evidence for multiple arthritogcnic cpitopes on the collagen molecule. J. Immunol. 1985; 135: 2443
  • Heinegardth D., Paulson M. Cartilage. Meth. Enzymol. 1987; 145: 336
  • Terato K., Hasty K. A., Cremer M. A., Stuart J. M., Townes A. S., Kang A. H. Collagen-induced arthritis in mice. Localization of an arthritogenic determinant to a fragment of the type II collagen molecule. J. Exp. Med. 1985; 162: 637
  • Myers L. K., Seyer J. M., Stuart J. M., Terato K., David C. S., Kang A. H. T cell epitopes of type II collagen that regulate murine collagen-induced arthritis. J. Immunol. 1993; 151: 500
  • Myers L. K., Terato K., Seyer J. M., Stuart J. M., Kang A. H. Characterization of a tolerogenic T cell epitope of type II collagen and its relevance to collagen-induced arthritis. J. Immunol. 1992; 149: 1439
  • Myers L. K., Stuart J. M., Seyer J. M., Kang A. H. Identification of an immunosuppressivc cpitopc of type II collagen that confers protection against collagen-induced arthritis. J. Exp. Med. 1989; 170: 1999
  • Myers L. K., Rosloniec E. F., Seyer J. M., Stuart J. M., Kang A. H. A synthetic peptide analogue of a determinant of type II collagen prevents the onset of collagen-induced arthritis. J. Immunol. 1993; 150: 4652
  • Griffiths M. M., Cremer M. A., Harper D. S., McCall S., Cannon G. W. Immunogenetics of collagen-induced arthritis in rats. Both MHC and non-MHC gene products determine the epitope specificity of immune response to bovine and chick type II collagens. J. Immunol. 1992; 149: 309
  • Eyre D. R., Muir H. Characterization of the major CNBr-derived peptides or porcine type II collagen. Connective Tissue Research 1975; 3: 165
  • Miller E. J. Isolation and characterization of the cyanogen bromide peptides from the α1 (II) chain of chick cartilage collagen. Biochem. 1971; 10: 3030
  • Terato K., Cremer M. A., Hasty K. A., Kang A. H., Hasty D. L., Townes A. S. Physiochemical and immunological studies of the renature αl (II) chains and isolated cyanogen bromide peptides of type II collagen. Collagen Res. Rel. 1985; 5: 469
  • Ku G., Kronenberg M., Peacock D. J., Tempst P., Banquerigo M. L., Braun B. S., Reeve J. R., Brahn E. Prevention of experimental arthritis with a peptide fragment of type II collagen. Eur. J. Immunol. 1993; 23: 591
  • Moder K. G., Luthra H. S., Kubo R., Griffiths M. M., David C. S. Prevention of collagen-induced arthritis in mice by treatment with an antibody directed against the T cell receptor alpha beta fremwork. Autoimmunity 1992; 11: 219
  • Horn J. T., Butler L. D., Biedl P. E., Bendele A. M. The progression of the inflammation in established collagen-induced arthritis can be altered by treatments with immunological or pharmacological agents which inhibit T cell activities. Eur. J. Immunol. 1988; 18: 881
  • Horn J. T., Estridge T., Cole H., Gliszczynski V., Bendele A. Effects of various anti-T cell receptor antibodies on the development of type II collagen-induced arthritis in mice. Immunol. Invest. 1993; 22: 257
  • Jensen P. E., Kapp J. A., Pierce C. W. The role of suppressor T cells in the expression of immune response gene function. J. Mol. Cell. Immunol. 1987; 3: 267
  • Olivcira D. B., Mitchison N. A. Immune suppression genes. Clin. Exp. Immunol. 1989; 75: 167
  • Cremer M. A., Terato K., Watson W. C., Griffiths M. M., Townes A. S., Kang A. H. Collagen-induced arthritis in rats. Examination of the epitope specificities of circulating and cartilage-bound antibodies produced by outbred and inbred rats using cyanogen bromide-derived peptides purified from hetcrologous and homologous type II collagen. J. Immunol. 1992; 149: 1045
  • Seki N., Sudo Y., Yoshioka T., Sugihara S., Fujisu T., Sakuma S., Ogawa T., Hamaoka T., Scnoh H., Fujiwara H. Type II collagen-induced murine arthritis. I. Induction and perturbation of arthritis require synergy between humoral and cell-mediated immunity. J. Immunol. 1988; 140: 1477
  • Terato K., Hasty K. A., Reife R. A., Cremer M. A., Kang A. H., Stuart J. M. Induction of arthritis with monoclonal antibodies to collagen. J. Immunol. 1992; 148: 2103
  • Myers L. K., Stuart J. M., Kang A. H. A CD4 cell is capable of transferring suppression of collagen-induced arthritis. J. Immunol. 1989; 143: 3976
  • Kong Y. M., Giraldo A. A., Waldmann H., Cobbold S. P., Fuller B. E. Resistance to experimental autoimmune thyroiditis: L3T4+ cells as mediators of both thyroglobulin-activated and TSH-induced suppression. Clin. Immunol. Immunopathol. 1989; 51: 38
  • Parish N. M., Roitt I. M., Cooke A. Phenotypic characteristics of cells involved in induced suppression to murine experimental autoimmune thyroiditis. Eur. J. Immunol. 1988; 18: 1463
  • Gahring L. C., Weiglc W. O. The induction of peripheral T cell unresponsiveness in adult mice by monomeric human gamma globulin. J. Immunol. 1989; 143: 2094
  • Marcelletti J. F., Ohara J. I., Katz D. H. Collagen-induced arthritis in mice. Relationship of collagen-specific and total IgE synthesis to disease. J. Immunol. 1991; 147: 4185

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.